España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Pluri
PLUR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.50
0.02
0.45%
At close: -
$4.25
-0.25
-5.56%
After Hours: Jan 30, 4:37 PM EDT
Get Report
Comment
Pluri (PLUR) Forecast
News
Earnings
Pluri (PLUR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Pluri (NASDAQ:PLUR) Stock
Pluri Stock (NASDAQ: PLUR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 23, 2025
Pluri shares are trading higher after the com...
Benzinga Newsdesk
Pluri Announces $6.5M Private Placement With ...
Benzinga Newsdesk
Thursday, December 19, 2024
Pluri shares are trading higher after the com...
Benzinga Newsdesk
Pluri Applauds Mesoblast For FDA Approval Of ...
Benzinga Newsdesk
Monday, November 25, 2024
Pluri Assesses Readiness For Mass Production ...
Benzinga Newsdesk
Monday, November 11, 2024
Brainstorm Cell Therapeutics and Pluri shares...
Benzinga Newsdesk
BrainStorm Enters Memorandum Of Understanding...
Benzinga Newsdesk
Monday, October 28, 2024
Pluri Secures Israel Funding for MAIT Cell Ca...
Benzinga Newsdesk
Thursday, July 18, 2024
Pluri Partners with Kadimastem to Advance Cel...
Benzinga Newsdesk
Monday, July 08, 2024
Pluri Announced €1M Proof Of Concept Agreemen...
Benzinga Newsdesk
Tuesday, July 02, 2024
Pluri's Has Appointed Liat Zalts As The Compa...
Benzinga Newsdesk
Tuesday, June 18, 2024
Pluri's Majority-Owned Joint Venture, Ever Af...
Benzinga Newsdesk
Thursday, June 06, 2024
Pluri Says US NIAID Will Provide Company With...
Benzinga Newsdesk
Monday, May 20, 2024
Pluri Collaborated With Wilk Technologies To ...
Benzinga Newsdesk
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Pluri shares are trading higher after the com...
Benzinga Newsdesk
Pluri Introduces Groundbreaking Immune Cell E...
Benzinga Newsdesk
Monday, April 01, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Thursday, March 28, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, March 27, 2024
Pluri Inc. Announces 1-for-8 Reverse Share Sp...
Benzinga Newsdesk
Thursday, March 14, 2024
Pluri Announced That Its CDMO Division Has Si...
Benzinga Newsdesk
Monday, March 11, 2024
Pluri Receives Patent Approval For 3D Bioreac...
Benzinga Newsdesk
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Pluri Unveils Sustainable Cell-Based Coffee T...
Benzinga Newsdesk
Monday, January 08, 2024
Pluri Has Launched A New Business Division Of...
Benzinga Newsdesk
Thursday, December 21, 2023
Pluri Disclosed Signing An Agreement Assignin...
Benzinga Newsdesk
Tuesday, October 31, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, August 28, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, August 16, 2023
Pluri Announced The Publication Of An Article...
Benzinga Newsdesk
Monday, July 31, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, July 14, 2023
Pluri Director Awarded $74K Worth of Stock Options
Benzinga Insights
Thursday, July 13, 2023
Board Member at Pluri Acquires Company Stock Options Worth 100,000 Shares
Benzinga Insights
Tuesday, July 11, 2023
Pluri Gets $4.2M Contract To Advance Development Of Treatment For Radiation Syndrome
Nabaparna Bhattacharya
Pluri Signed $4.2M Contract With US National ...
Benzinga Newsdesk
Tuesday, June 06, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Friday, March 24, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, February 13, 2023
Pluri Q2 EPS $(0.24) Beats $(0.32) Estimate
Benzinga Newsdesk
Friday, January 13, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, December 15, 2022
Pluri Prices $8.2M Private Placement Offering...
Benzinga Newsdesk
Friday, October 28, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, October 13, 2022
Pluri Received Letter From Nasdaq Dated Octob...
Benzinga Newsdesk
Tuesday, September 27, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 19, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Friday, September 02, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 01, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
